Asia-Pacific Gatifloxacin Market Research Report Offer Forecast and Analysis Through 2022
Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family that is sold under the brand names Gatiflo, Tequin and Zymar. Gatifloxacin inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Gatifloxacin is widely used in the pharmaceutical and healthcare sector on account of its effectiveness in managing a host of ailments. A new report titled "Asia-Pacific Gatifloxacin Market Report 2017" added to the comprehensive database of Market Research Hub (MRH) offers detailed insights into the key factors affecting Gatifloxacin sales...
View full press release